TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism.
about
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanismVascular dysfunction following polymicrobial sepsis: role of pattern recognition receptorsImpaired heart rate regulation and depression of cardiac chronotropic and dromotropic function in polymicrobial sepsis.TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling.Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms.Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation.Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.An ongoing search for potential targets and therapies for lethal sepsisThe toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage.Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model.Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptakeCpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signalingSR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages.Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury.Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function.Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis.The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signalingToll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsisTargeting HMGB1 in the treatment of sepsisToll-like receptors: new players in myocardial ischemia/reperfusion injury.Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia.Zymosan-Induced Peritonitis: Effects on Cardiac Function, Temperature Regulation, Translocation of Bacteria, and Role of Dectin-1.Enhanced Glycolytic Metabolism Contributes to Cardiac Dysfunction in Polymicrobial Sepsis.MicroRNA-125b Prevents Cardiac Dysfunction in Polymicrobial Sepsis by Targeting TRAF6-Mediated Nuclear Factor κB Activation and p53-Mediated Apoptotic Signaling.Association of myeloid cells of triggering receptor-1 with left ventricular systolic dysfunction in BALB/c mice with sepsis.Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner.Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage.Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice.
P2860
Q34062721-F46B0A72-FB3F-46A8-8736-2A4739A27D6FQ34412514-AEB004C0-F278-45B1-8258-B1D9C1C105ACQ34978323-0E3BEDA4-B9C0-44C4-A49D-59F0B8E218ADQ35118932-7E5D9932-4C04-4B78-9EC0-59BF2B5EEA93Q35124387-FC39E837-D559-45B5-BF6A-FA6FF2243019Q35315155-72E62313-8635-47A2-A6CE-2F6056EF9444Q35815694-ACB57DC0-0434-4F51-B9EC-0E816BE7C1ACQ35930160-4BCCE77B-8C25-4AC7-B31B-2BF9D7092DC5Q36103464-7DDE256C-2D11-48CC-A72E-4B37D86F643FQ36137078-BDE69C20-F31B-4BA5-B04B-894EEAF7BB5CQ36377158-66400F1B-0131-4D45-ACB7-3E27D5D47FF0Q36456832-9DAC79E8-8A32-48EF-988D-61A14EBEAC91Q36501225-0603DDA4-5B9F-45CC-BEC7-D5F4FC62F4F8Q36596636-50A9DE34-58B9-4431-A47B-F36D0C62CFBDQ36796964-8E139B80-58D5-441F-9D5B-3754351ED8CFQ36825545-CD878791-FD5D-4BAE-9203-C306D77E2858Q36957263-3C9DFC69-9F3B-4C14-AACB-145BB2B01D8AQ37019795-3B14AC63-9E6A-4BA8-891B-65626976BAB6Q37622744-3D5E11D8-7DA9-408C-88F2-1C9550CC1F42Q37810952-4769551D-EEED-4E75-8747-05F0F968953EQ38888128-23941B82-771C-4A29-88F6-FF64F735CC02Q39630006-671B39B1-3770-476E-9E3F-386D1C0C672FQ40262427-DABF8D96-08B3-4E0E-B792-55737BA714FEQ40523308-54AE6ED6-1D17-4D07-95B5-C1175BC90600Q40544710-17E87B50-C641-4EFF-A79B-DFA4C7DCC645Q42263287-0E299119-27EC-48F7-B85C-91E18745106EQ45795481-94DCD85A-83D4-46DB-9629-088CECDC0AA1Q55042826-337B9A5C-836A-445C-A9B3-35B8BAC480DC
P2860
TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@ast
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@en
type
label
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@ast
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@en
prefLabel
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@ast
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@en
P2093
P2860
P1476
TLR2 ligands attenuate cardiac ...... 3-kinase-dependent mechanism.
@en
P2093
Chuanfu Li
David L Williams
Jim Kelley
John Kalbfleisch
Krishna Singh
Race L Kao
Tuanzhu Ha
P2860
P304
P356
10.1152/AJPHEART.01109.2009
P577
2010-01-08T00:00:00Z